1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
New Antidiabetic Agents for the Treatment of Heart Failure in Hypertensive Patients
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2023
-
Mark
Galectin-4 is associated with diabetes and obesity in a heart failure population
(
- Contribution to journal › Article
-
Mark
Metabolite Profiling in a Diet-Induced Obesity Mouse Model and Individuals with Diabetes: A Combined Mass Spectrometry and Proton Nuclear Magnetic Resonance Spectroscopy Study
(
- Contribution to journal › Article
- 2021
-
Mark
Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness
(
- Contribution to journal › Article
-
Mark
Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: : A Descriptive Study from a Swedish Cohort
(
- Contribution to journal › Article
- 2020
-
Mark
Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality : a prospective study
(
- Contribution to journal › Article
-
Mark
Proteomic exploration of common pathophysiological pathways in diabetes and cardiovascular disease
2020) In ESC Heart Failure(
- Contribution to journal › Article
- 2019
-
Mark
Prospective associations between cardiac stress, glucose dysregulation and executive cognitive function in Black men : The Sympathetic activity and Ambulatory Blood Pressure in Africans study
(
- Contribution to journal › Article
-
Mark
Using a Targeted Proteomics Chip to Explore Pathophysiological Pathways for Incident Diabetes- The Malmö Preventive Project
(
- Contribution to journal › Article
-
Mark
Metabolically healthy obesity (MHO) in the Malmö diet cancer study - Epidemiology and prospective risks
(
- Contribution to journal › Article